We investigated the changes in cancer cell proliferation, migration, and invasion after modulating the expression of MFN2. The expression of MFN2 was successfully downregulated in Cal62 cells using the CRISPR/Cas9 KO method (Supplementary Fig. 2). This evidence concerns the gene MFN2 and cancer.